LifeSafe (LIFS), a fire safety technology business, announced the launch of its new patent pending wildfire extinguishing fluid, Wildfire Pro. Wildfire Pro is a non-toxic and fluorine-free wildfire fluid engineered to suppress, extinguish and prevent the spread of devastating wildfires. Unlike current fluorine-based fluid solutions, Wildfire Pro’s non-toxic and fluorine-free properties pose no chemical threat to wildlife or natural ecosystems. LIFS said it was proud to announce another new fluid to add to its family of fire suppression technologies. Wildfire Pro provides a complete solution to both tackle and prevent devastating wildfires. The launch of the new fluid will open up new partnership and geographic markets for the Group.
Comment: It would appear that it will be the non-retail / industrial part of the LifeSafe business which will lead the way for LIFS. Given recent concerns regarding the retail business, new fluids such as Wildfire Pro could really turn around the company, and its share price.
Zenova Group (ZED), the innovative fire suppression and interdiction solutions Company, provided an update on the progress of its market-leading Zenova FX fire extinguisher range. ZED said the recent Government and industry product demonstration, as well as the independent PFAS testing, reinforces its view of the specific performance capabilities of its Zenova FX extinguisher products and its ability to demonstrate that in the marketplace. This initial order from Germany is just the first step in gaining market penetration and it is confident sales successes should follow on from the increasing market profile of the Zenova FX series.
Comment: It would appear that the start of this week is all about putting out fires. In the case of ZED it can be seen that the sales breakthrough in Germany should be enough to reignite the summer recovery in the share price.
Powerhouse Energy Group (PHE), a company pioneering integrated technology that converts non-recyclable waste into low carbon energy, announced that Paul Emmitt, Chief Executive Officer of the Company, acquired 3,574,901 ordinary shares of 0.5p each in the Company on 8 December 2023. Further to this transaction, Mr Emmitt is beneficially interested in 3,574,901 Ordinary Shares, which represents 0.09% of the Company’s issued ordinary share capital.
Comment: In current bear market conditions, one of the few positive levels that small cap management have is to lead from the front in terms of buying their shares. In this case Emmitt is splashing the cash in the wake of the appointment of a new PHE CFO last week.
Synectics (SNX) Trading update for the Y/E Nov report it is expected to be materially ahead of market expectations, mainly due to a strong Oil and Gas market. SNX designs and integrates advanced security and surveillance systems to protect people, property, and assets. Interims showed a sharp increase in underlaying profits to £0.8m and EPS up 76% to 3.7p so the full year could give an EPS of 10p plus. The update added the forward order book is £28.6m so the 2024 y/e has started well, and gross profit margins are cir. 45%. Net cash is ahead at £4.6m with undrawn bank facilities of £3m which funds organic growth and an increased dividend. The Company remains focused on the delivery of specialist surveillance systems – including a flexible, open-architecture software platform and specialist hardware for challenging environments – to targeted specialist markets, including gaming, oil & gas, and public space.
Comment: At 105p with a £18m mkt cap the potential P/E of 11x or lower makes the shares look undervalued.
Blencowe Resources (BRES), provided an update of the progress of significant works currently underway across four continents as part of the DFS for its Orom-Cross graphite project in Northern Uganda. Test work is currently nearing completion on a number of phases critical for the meeting of staged milestone payments from the DFC and also for additional discussions with potential off-take firms, specifically for the large flake product generated by the project. BRES said it was making progress on all parts of the Definitive Feasibility Study with key actions currently underway in Uganda, China, Australia and the United States respectively.
Comment: Big project small cap mining companies have had a tough year, as such concepts are normally flying by the seat of their pants, even in the best of times. In 2023, which really is not in such a category, investors have tended to be rather fussy. This is even when presented by decent milestones such as BRES is delivering at the moment.
Dekel Agri-Vision (DKL), the West African agriculture company, provided a record November 2023 monthly production update for its Ayenouan palm oil project in Côte d’Ivoire. DKL said a 152.4% increase in CPO production in November compared to last year was an exceptional outcome and together with a significant improvement in the CPO extraction rate has contributed to a record November monthly performance. It looks forward to the Palm Oil Operation finishing the year strongly and reporting its annual 2023 production results in early January.
Comment: DKL turned the corner as far as production on the CPO front some time ago, but has really surged as 2023 comes to a close. The shares being near year lows seems totally out of kilter.
Reabold Resources (RBD), the oil & gas investing company, announced that it has exercised the Second Option to subscribe for 116 new ordinary shares in LNEnergy Limited through an aggregate further investment of £1,650,000. Reabold said it was excited by the potential of the Colle Santo project and confident in its decision to invest further in LNEnergy. The formalisation of the Technical Scientific Committee at the University of Chieti-Pescara shows constructive local stakeholder engagement in the Colle Santo project and follows on from positive regulatory progress taking place at a government level, as Italy looks to secure domestic energy supply.
Comment: RBD continues to top up on LNEnergy, with an unusual degree of enthusiasm. Clearly, Italy’s energy security is a theme here.
Poolbeg Pharma (POLB), a biopharmaceutical company, announced key insights from its poster presentation at the prestigious, 65th American Society of Hematology Annual Meeting and Exposition, San Diego. POLB said presenting at ASH is strong validation of POLB 001’s potential and it was delighted to have the opportunity to continue its productive partnering discussions at this prestigious conference.
Comment: It is only right and proper that POLB should be spreading the word regarding the potential of POLB 001, and of course the prospects for marketing it, and partnerships. POLB shares really should be on the right side of 10p again.
Author
